Smith & Nephew (NYSE:SNN) Downgraded to Neutral Rating by UBS Group

Smith & Nephew (NYSE:SNN) was downgraded by UBS Group from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday,Briefing.com Automated Import reports.

Other analysts also recently issued research reports about the stock. Canaccord Genuity Group reaffirmed a “hold” rating and set a $27.00 price target on shares of Smith & Nephew in a report on Wednesday, February 26th. StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, February 26th. Four equities research analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $27.00.

Smith & Nephew Stock Performance

Shares of SNN stock opened at $29.87 on Wednesday. The company’s 50-day moving average is $26.10 and its 200 day moving average is $27.17. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The company has a market capitalization of $13.06 billion, a price-to-earnings ratio of 13.83, a price-to-earnings-growth ratio of 1.26 and a beta of 0.83. Smith & Nephew has a one year low of $23.65 and a one year high of $31.72.

Institutional Investors Weigh In On Smith & Nephew

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. River Road Asset Management LLC raised its position in shares of Smith & Nephew by 64.0% during the fourth quarter. River Road Asset Management LLC now owns 2,032,016 shares of the medical equipment provider’s stock valued at $49,947,000 after buying an additional 792,829 shares during the last quarter. J. Goldman & Co LP purchased a new position in shares of Smith & Nephew in the fourth quarter valued at $47,700,000. Brandes Investment Partners LP grew its holdings in shares of Smith & Nephew by 11.4% in the fourth quarter. Brandes Investment Partners LP now owns 1,363,039 shares of the medical equipment provider’s stock valued at $33,504,000 after purchasing an additional 138,994 shares in the last quarter. Clark Estates Inc. NY grew its holdings in shares of Smith & Nephew by 16.8% in the fourth quarter. Clark Estates Inc. NY now owns 800,000 shares of the medical equipment provider’s stock valued at $19,664,000 after purchasing an additional 115,000 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its holdings in shares of Smith & Nephew by 11.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 535,350 shares of the medical equipment provider’s stock valued at $13,159,000 after purchasing an additional 57,014 shares in the last quarter. Institutional investors own 25.64% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.